Talc Pleurodesis via Video-Assisted Thoracoscopic Surgery(VATS) in Malignant Pleural Effusions.
10.4046/trd.1998.45.4.785
- Author:
Sang Joon PARK
1
;
Seok Jin AHN
;
Kyeong Woo KANG
;
Young Min KOH
;
Gee Young SUH
;
Man Pyo CHUNG
;
Ho Joong KIM
;
O Jung KWON
;
Kwhan Mien KIM
;
Jhin Gook KIM
;
Young Mog SHIM
;
Chong H RHEE
Author Information
1. Department of Medicine, Samsung Medical Center, College of Medicine, Sung Kyun Kwan University, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
Malignant pleural effusion;
Talc;
Pleurodesis;
Video-assisted tboracoscopic snrgery(VATS)
- MeSH:
Drainage;
Follow-Up Studies;
Lung;
Medical Records;
Mortality;
Pleural Effusion, Malignant*;
Pleurodesis*;
Postoperative Complications;
Radiography, Thoracic;
Recurrence;
Respiratory Insufficiency;
Retrospective Studies;
Talc*;
Thoracic Surgery, Video-Assisted
- From:Tuberculosis and Respiratory Diseases
1998;45(4):785-794
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: Chemical pleurodesis is a widely used method for the control of symptomatic and recurrent malignant pleural effusions. Tab has been accepted to k the most effective sclerosing agent for chemical pleurodesis. This study was undertaken to evaluate the usefulness of talc pleurodesis via video-assisted thoracoscopic surgery(VATS) in treatment of malignant pleural effusion& METHODS: A retrospective analysis of the medical records and radiographic findings was performed. The success of the procedure was defined as daily pleural fluid drainage below l00microliter within 1 week after pleurodesis and complete expansion of tie lung on simple chest radiograph. Recurrence was defined as reaccumulation of pleural fluid on follow-up chest radiographs, arid complete response as no fluid accumulation on follow-up chest radiographs. RESULTS: Between October 1994 and August 1996, talc pleurodesis via VATS was performed in 35 patient& Duration of follow-up ranged from 5 days to 828 days(median 79days). The initial success rate of procedure was 8S.6%(31 of 35 cases). Complete responses were observed in 92.8% at3O days, 75.7% at 90 days and 64.9% at 180 days. Postoperative complications were fever(54.3%), subcutaneous emphysema(11.4%), reexpansion pulmonary edema(2.9o%) and respiratory failure(5.7%). But procedure related mortality or respiratory failure was not found. CONCLUISON: Talc p1eurodesis via VATS is a safe and effective method F or the control of symptomatic malignant pleural effusions.
